Fifth

Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments

Retrieved on: 
Thursday, March 28, 2024

WILMETTE, Ill., March 28, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced fourth quarter and full-year 2023 financial results and summarized recent developments.

Key Points: 
  • WILMETTE, Ill., March 28, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced fourth quarter and full-year 2023 financial results and summarized recent developments.
  • Results for the Fourth Quarter and Year Ended December 31, 2023, Compared to the Fourth Quarter and Year Ended December 31, 2022
    Cash, cash equivalents and short-term investments as of December 31, 2023, were $7.3 million.
  • R&D expenses for the fourth quarter of 2023 were $1.0 million compared to $2.1 million for the fourth quarter of 2022.
  • G&A expenses for the fourth quarter of 2023 were $0.9 million, compared to $0.8 million for the fourth quarter of 2022.

NCLA Asks Supreme Court to Resolve Circuit Split over Standing in Social Media Censorship Cases

Retrieved on: 
Wednesday, March 27, 2024

NCLA’s petition asks the Court to resolve a circuit split between the Fifth and Sixth Circuits on what plaintiffs must show to satisfy Article III standing in censorship cases against the government.

Key Points: 
  • NCLA’s petition asks the Court to resolve a circuit split between the Fifth and Sixth Circuits on what plaintiffs must show to satisfy Article III standing in censorship cases against the government.
  • The petition urges the Court to overturn the U.S. Court of Appeals for the Sixth Circuit ruling that NCLA clients Mark Changizi, Michael Senger, and Daniel Kotzin lacked standing to challenge the censorship regime that silenced them.
  • The Supreme Court should resolve the resulting circuit split on this standing issue in the First Amendment context, at least holding NCLA’s Changizi cert petition until it issues a decision in Murthy.
  • NCLA released the following statements:
    “The Changizi allegations regarding government-induced social media censorship are nearly identical to those made in Murthy v. Missouri.

Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants

Retrieved on: 
Wednesday, March 20, 2024

The Company can call the warrants if it reports equal to or greater than $4.5 million of net sales for the quarter ending March 31, 2025 which will require exercise within 10 business days.

Key Points: 
  • The Company can call the warrants if it reports equal to or greater than $4.5 million of net sales for the quarter ending March 31, 2025 which will require exercise within 10 business days.
  • The closing of the offering is expected to occur on or about March 22, 2024, subject to the satisfaction of customary closing conditions.
  • The gross proceeds to the Company from this offering are expected to be approximately $16.0 million before deducting the placement agent fees and other offering expenses payable by the Company.
  • The Company intends to use the net proceeds from this offering to fund commercial sales development, research, working capital, and other general corporate purposes.

Supreme Court Hears Oral Argument in Pivotal NCLA Case Against Gov’t Social Media Censorship

Retrieved on: 
Monday, March 18, 2024

The vast, coordinated silencing of First Amendment-protected speech has targeted influential, highly qualified voices including doctors and scientists like Drs.

Key Points: 
  • The vast, coordinated silencing of First Amendment-protected speech has targeted influential, highly qualified voices including doctors and scientists like Drs.
  • We went to social media to voice our opinions and were silenced by government employees who bullied social media snowflakes into silencing our voices.
  • In the Murthy v. Missouri case, the Supreme Court has the opportunity to restore the First Amendment in this country.
  • That is what the government did here, and if that is allowed then the First Amendment is a dead letter.”

Unleashing the Power: How the “Fifth Estate” Drives Decision-Makers in Business and Politics

Retrieved on: 
Friday, March 22, 2024

By leveraging the positive aspects of this emerging influence, society can drive meaningful action on the world’s critical issues.

Key Points: 
  • By leveraging the positive aspects of this emerging influence, society can drive meaningful action on the world’s critical issues.
  • “The world’s hierarchical structure is flattening,” said Marian Salzman, PMI’s Senior Vice President & Chief Corporate Citizenship Officer.
  • Leaders must not underestimate the impact of the Fifth Estate phenomena nor dismiss its potential to disrupt corporate power structures.
  • Businesses, policymakers, and civil society must find ways to help ensure this emerging force moves society in a positive direction.”

LUXURY TRAVEL & FASHION ACCESSORIES BRAND SILVER & RILEY NAMES ACTRESS, MODEL & ENTREPRENEUR VANESSA SIMMONS AS BRAND AMBASSADOR

Retrieved on: 
Tuesday, March 19, 2024

LOS ANGELES, March 19, 2024 /PRNewswire/ -- Luxury travel & fashion accessories brand Silver & Riley has named actress, model & entrepreneur Vanessa Simmons as the brand's newest ambassador.

Key Points: 
  • LOS ANGELES, March 19, 2024 /PRNewswire/ -- Luxury travel & fashion accessories brand Silver & Riley has named actress, model & entrepreneur Vanessa Simmons as the brand's newest ambassador.
  • Additionally, this marks a significant milestone for Simmons as she returns to the fashion industry after nearly two decades.
  • Silver & Riley is available now through the brand's official website, www.silverandriley.com and through luxury retail partners including Nordstrom and Saks Off Fifth.
  • Follow Silver & Riley on Instagram @SilverandRiley and Vanessa Simmons on Instagram @VanessaJSimmons .

NCLA Amicus Brief Asks U.S. Supreme Court to Reject NLRB-Specific Preliminary Injunction Standard

Retrieved on: 
Wednesday, February 28, 2024

The U.S. Court of Appeals for the Sixth Circuit upheld the injunction granted below due to prior circuit precedent.

Key Points: 
  • The U.S. Court of Appeals for the Sixth Circuit upheld the injunction granted below due to prior circuit precedent.
  • NCLA’s brief asks the Supreme Court to reject this textually baseless test, reverse the Sixth Circuit’s ruling, and require NLRB to satisfy the same injunction standard as every other litigant.
  • The Supreme Court has clarified, in many other contexts, that federal courts may not issue preliminary injunctions unless the party seeking the P.I.
  • NCLA asks the Supreme Court to eliminate this coercive dynamic and force NLRB to meet the traditional preliminary injunction standard rather than the Sixth Circuit’s preferential version.

Supreme Court Hears Oral Argument in NCLA’s Cargill Case Against ATF’s Unilateral Bump Stock Ban

Retrieved on: 
Wednesday, February 28, 2024

ATF issued its interpretive Final Rule in 2018 defining semi-automatic firearms equipped with bump stocks as “machineguns,” which federal law prohibits.

Key Points: 
  • ATF issued its interpretive Final Rule in 2018 defining semi-automatic firearms equipped with bump stocks as “machineguns,” which federal law prohibits.
  • The rule required Mr. Cargill and every other bump-stock owner nationwide to either destroy or turn in their legally purchased devices.
  • This case tasks the Supreme Court with resolving these conflicting opinions.
  • A bump stock does not alter the trigger on a semi-automatic weapon, so a bump stock does not turn a semi-automatic weapon into a machine gun.”

The Knightscope K5 is Margaritaville’s Newest Team Member

Retrieved on: 
Monday, February 26, 2024

Knightscope, Inc. [Nasdaq: KSCP] (“Knightscope” or the “Company”), a leading innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, today announces that its Fifth Generation K5 Autonomous Security Robot (“ASR”) is the newest member of the team at Margaritaville Resort Casino in Bossier City, LA.

Key Points: 
  • Knightscope, Inc. [Nasdaq: KSCP] (“Knightscope” or the “Company”), a leading innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, today announces that its Fifth Generation K5 Autonomous Security Robot (“ASR”) is the newest member of the team at Margaritaville Resort Casino in Bossier City, LA.
  • The master agreement enables corporatewide expansion of Knightscope’s technologies to 43 properties across the United States.
  • View the full release here: https://www.businesswire.com/news/home/20240226734819/en/
    The Knightscope K5 is Margaritaville’s Newest Team Member (Photo: Business Wire)
    The Knightscope ASR is driven by proprietary AI software that enhances safety measures at the property while providing visitors with a unique, interactive guest experience with Margaritaville-branded graphics, a client-chosen voice for custom audio broadcast messaging, improved access to emergency services and plenty of opportunities for robot selfies.
  • The K5 is the Company’s fully autonomous (i.e., no human intervention needed to operate) outdoor robot capable of watching over a property 24/7/365.

Neurophet introduces AI-powered brain imaging analysis technology at AD/PD 2024

Retrieved on: 
Monday, March 4, 2024

SEOUL, South Korea, March 4, 2024 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company for brain disease, announced its participation in the international conference on Alzheimer's and Parkinson's diseases and related neurological disorders (AD/PD 2024).

Key Points: 
  • At this conference, Neurophet will introduce Alzheimer's disease treatment related technologies planned to be commercialized such as analysis of the side effect and amyloid-positive prediction.
  • Neurophet AQUA analyzes brain atrophy and white matter hyperintensities (WMH) found in brain MRI of most Alzheimer's disease patients.
  • Neurophet SCALE PET provides quantitative regional amyloid beta deposition, known as the causative agent of Alzheimer's disease, using PET images.
  • Neurophet plans to launch total solution for Alzheimer's disease treatment including ARIA analysis, since Neurophet has the technology to analyze ARIA.